Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1993 Aug 1;178(2):723–730. doi: 10.1084/jem.178.2.723

The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn

PMCID: PMC2191101  PMID: 7688033

Abstract

Fas is a cell surface protein of the tumor necrosis factor receptor, nerve growth factor receptor, CD40 family, and is involved in the control of lymphocyte apoptosis. A mutation in the Fas gene in MRL/lpr mice results in massive lymphoproliferation (lpr) and accelerated autoimmunity. To further study the nature of this defect, Fas mRNA expression was evaluated by reverse transcriptase polymerase chain reaction as well as by Northern blotting. These studies revealed that the wild-type Fas message was produced at approximately 10-fold lower levels in the lpr compared with the ++ substrain of MRL mice. In addition to the wild-type transcript, lpr mice also synthesized chimeric transcripts containing an insertion of the early retrotransposon (ETn). Molecular cloning and nucleotide sequencing of a Fas-ETn chimeric cDNA suggested that the striking reduction in wild- type Fas mRNA levels and the presence of aberrant transcripts in MRL/lpr mice are most likely explained by the insertion of the ETn retrotransposon into an intron of the Fas gene and induction of alternative splicing involving the 5' ETn long terminal repeat.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi M., Watanabe-Fukunaga R., Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1756–1760. doi: 10.1073/pnas.90.5.1756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Badley J. E., Bishop G. A., St John T., Frelinger J. A. A simple, rapid method for the purification of poly A+ RNA. Biotechniques. 1988 Feb;6(2):114–116. [PubMed] [Google Scholar]
  3. Breathnach R., Chambon P. Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem. 1981;50:349–383. doi: 10.1146/annurev.bi.50.070181.002025. [DOI] [PubMed] [Google Scholar]
  4. Brûlet P., Kaghad M., Xu Y. S., Croissant O., Jacob F. Early differential tissue expression of transposon-like repetitive DNA sequences of the mouse. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5641–5645. doi: 10.1073/pnas.80.18.5641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  6. Cohen P. L., Eisenberg R. A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 1991;9:243–269. doi: 10.1146/annurev.iy.09.040191.001331. [DOI] [PubMed] [Google Scholar]
  7. Elkon K. B., Hines J. J., Chu J. L., Parnassa A. Epitope mapping of recombinant HeLa SmB and B' peptides obtained by the polymerase chain reaction. J Immunol. 1990 Jul 15;145(2):636–643. [PubMed] [Google Scholar]
  8. Elliott E., Rathbun D., Ramsingh A., Garberi J., Flaherty L. Genetics and expression of the Q6 and Q8 genes. An LTR-like sequence in the 3' untranslated region. Immunogenetics. 1989;29(6):371–379. doi: 10.1007/BF00375865. [DOI] [PubMed] [Google Scholar]
  9. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  10. Freier S. M., Kierzek R., Jaeger J. A., Sugimoto N., Caruthers M. H., Neilson T., Turner D. H. Improved free-energy parameters for predictions of RNA duplex stability. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9373–9377. doi: 10.1073/pnas.83.24.9373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Izui S., Kelley V. E., Masuda K., Yoshida H., Roths J. B., Murphy E. D. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol. 1984 Jul;133(1):227–233. [PubMed] [Google Scholar]
  12. Keshet E., Schiff R., Itin A. Mouse retrotransposons: a cellular reservoir of long terminal repeat (LTR) elements with diverse transcriptional specificities. Adv Cancer Res. 1991;56:215–251. doi: 10.1016/s0065-230x(08)60482-0. [DOI] [PubMed] [Google Scholar]
  13. Kotzin B. L., Babcock S. K., Herron L. R. Deletion of potentially self-reactive T cell receptor specificities in L3T4-, Lyt-2- T cells of lpr mice. J Exp Med. 1988 Dec 1;168(6):2221–2229. doi: 10.1084/jem.168.6.2221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Matsuzawa A., Moriyama T., Kaneko T., Tanaka M., Kimura M., Ikeda H., Katagiri T. A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse. J Exp Med. 1990 Feb 1;171(2):519–531. doi: 10.1084/jem.171.2.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Miyawaki T., Uehara T., Nibu R., Tsuji T., Yachie A., Yonehara S., Taniguchi N. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol. 1992 Dec 1;149(11):3753–3758. [PubMed] [Google Scholar]
  16. Morse H. C., 3rd, Davidson W. F., Yetter R. A., Murphy E. D., Roths J. B., Coffman R. L. Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset. J Immunol. 1982 Dec;129(6):2612–2615. [PubMed] [Google Scholar]
  17. Owen-Schaub L. B., Yonehara S., Crump W. L., 3rd, Grimm E. A. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol. 1992 Mar;140(1):197–205. doi: 10.1016/0008-8749(92)90187-t. [DOI] [PubMed] [Google Scholar]
  18. Riley L. K., Marshall M. E., Coleman M. S. A method for biotinylating oligonucleotide probes for use in molecular hybridizations. DNA. 1986 Aug;5(4):333–337. doi: 10.1089/dna.1986.5.333. [DOI] [PubMed] [Google Scholar]
  19. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shell B. E., Collins J. T., Elenich L. A., Szurek P. F., Dunnick W. A. Two subfamilies of murine retrotransposon ETn sequences. Gene. 1990 Feb 14;86(2):269–274. doi: 10.1016/0378-1119(90)90289-4. [DOI] [PubMed] [Google Scholar]
  21. Shell B., Szurek P., Dunnick W. Interruption of two immunoglobulin heavy-chain switch regions in murine plasmacytoma P3.26Bu4 by insertion of retroviruslike element ETn. Mol Cell Biol. 1987 Apr;7(4):1364–1370. doi: 10.1128/mcb.7.4.1364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Singer P. A., Balderas R. S., McEvilly R. J., Bobardt M., Theofilopoulos A. N. Tolerance-related V beta clonal deletions in normal CD4-8-, TCR-alpha/beta + and abnormal lpr and gld cell populations. J Exp Med. 1989 Dec 1;170(6):1869–1877. doi: 10.1084/jem.170.6.1869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sonigo P., Wain-Hobson S., Bougueleret L., Tiollais P., Jacob F., Brûlet P. Nucleotide sequence and evolution of ETn elements. Proc Natl Acad Sci U S A. 1987 Jun;84(11):3768–3771. doi: 10.1073/pnas.84.11.3768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Steinmeyer K., Klocke R., Ortland C., Gronemeier M., Jockusch H., Gründer S., Jentsch T. J. Inactivation of muscle chloride channel by transposon insertion in myotonic mice. Nature. 1991 Nov 28;354(6351):304–308. doi: 10.1038/354304a0. [DOI] [PubMed] [Google Scholar]
  25. Warren R. W., Caster S. A., Roths J. B., Murphy E. D., Pisetsky D. S. The influence of the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains. Clin Immunol Immunopathol. 1984 Apr;31(1):65–77. doi: 10.1016/0090-1229(84)90190-9. [DOI] [PubMed] [Google Scholar]
  26. Watanabe-Fukunaga R., Brannan C. I., Copeland N. G., Jenkins N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992 Mar 26;356(6367):314–317. doi: 10.1038/356314a0. [DOI] [PubMed] [Google Scholar]
  27. Watanabe-Fukunaga R., Brannan C. I., Itoh N., Yonehara S., Copeland N. G., Jenkins N. A., Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol. 1992 Feb 15;148(4):1274–1279. [PubMed] [Google Scholar]
  28. Watson M. L., Rao J. K., Gilkeson G. S., Ruiz P., Eicher E. M., Pisetsky D. S., Matsuzawa A., Rochelle J. M., Seldin M. F. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med. 1992 Dec 1;176(6):1645–1656. doi: 10.1084/jem.176.6.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Weiss S., Johansson B. Integration of the transposon-like element ETn upstream of V lambda 2 in the cell line P3X63Ag8. J Immunol. 1989 Oct 1;143(7):2384–2388. [PubMed] [Google Scholar]
  30. Zheng J. H., Natsuume-Sakai S., Takahashi M., Nonaka M. Insertion of the B2 sequence into intron 13 is the only defect of the H-2k C4 gene which causes low C4 production. Nucleic Acids Res. 1992 Oct 11;20(19):4975–4979. doi: 10.1093/nar/20.19.4975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Zhou T., Bluethmann H., Eldridge J., Brockhaus M., Berry K., Mountz J. D. Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice. J Immunol. 1991 Jul 15;147(2):466–474. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES